A multifaceted risk management program to improve the reporting rate of patient safety incidents in primary care: a cluster-randomised controlled trial by Marc Chaneliere, Karine Buchet-Poyau, Maud Keriel-Gascou, Muriel Rabilloud, Cyrille Colin, Carole Langlois-Jacques, Sandrine Touzet

Get full text

Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group by Gilles Freyer, Anne Floquet, Olivier Tredan, Aurore Carrot, Carole Langlois-Jacques, Jonathan Lopez, Frédéric Selle, Cyril Abdeddaim, Alexandra Leary, Coraline Dubot-Poitelon, Michel Fabbro, Laurence Gladieff, Michele Lamuraglia

Get full text

Author Correction: Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group by Gilles Freyer, Anne Floquet, Olivier Tredan, Aurore Carrot, Carole Langlois-Jacques, Jonathan Lopez, Frédéric Selle, Cyril Abdeddaim, Alexandra Leary, Coraline Dubot-Poitelon, Michel Fabbro, Laurence Gladieff, Michele Lamuraglia

Get full text

Evaluating the impact of a standardised intervention for announcing decisions of withholding and withdrawing life-sustaining treatments on the stress of relatives in emergency depa... by Karim Tazarourte, Marion Douplat, Laurent Jacquin, Delphine Douillet, Fabien Subtil, Julie Haesebaert, Xavier Dubucs, Anne-Marie Schott-Pethelaz, Damien Viglino, Mathilde Marchal, Manon Verroul, Anne Termoz, Pauline Drouin, Estelle Bravant, Carole Langlois, Bénédicte Clément, Daniel Roux-Boniface, Frédéric Verbois, Marine Demarquet

Get full text